About Zambon Pharma
Zambon Pharma is a company based in Bresso (Italy) founded in 1906. Zambon Pharma has completed 1 acquisition, including Breath Therapeutics. Zambon Pharma offers products and services including Zambon Pharma, Zach System, and Zcube.
- Headquarter Bresso, Italy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Zambon India Private Limited
- Date of Incorporation 19 Jun, 2002
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$50.27 K (USD)-2.03as on Mar 31, 2023
-
Net Profit
-$61.9 K (USD)-4511.35as on Mar 31, 2023
-
EBITDA
-$100.39 K (USD)-118.63as on Mar 31, 2023
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Zambon Pharma
Zambon Pharma offers a comprehensive portfolio of products and services, including Zambon Pharma, Zach System, and Zcube.
Develops drugs and therapies to enhance patient health
Manufactures active ingredients for pharmaceutical use
Creates digital health innovations for patient support
Funding Insights of Zambon Pharma
Investors in Zambon Pharma
Zambon Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include European Investment Bank.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Finance and advisory services for infrastructure projects are provided.
|
Locked | Locked | Locked |
Investor details for Zambon Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zambon Pharma
Zambon Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Breath Therapeutics.
Investment portfolio details for Zambon Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Inhalation therapies are developed for severe respiratory orphan diseases.
|
Locked | Locked | 2016 | Locked |
Complete acquisition details for Zambon Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Zambon Pharma
Detailed financials for Zambon Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zambon Pharma Comparisons
Peer comparison for Zambon Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zambon Pharma
Detailed competitors of Zambon Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zambon Pharma
Complete news archive for Zambon Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zambon Pharma
Zambon Pharma was founded in 1906 and raised its 1st funding round 106 years after it was founded.
Zambon Pharma is headquartered in Bresso, Italy. It is registered at Bresso, Lombardy, Italy.
Roberto Tascione is the current CEO of Zambon Pharma.
Annual revenue of Zambon Pharma is $50.27K as on Mar 31, 2023.
Zambon Pharma was founded in 1906 in Bresso, Italy, within the pharmaceutical sector. Active pharmaceutical ingredients and finished drugs are developed and manufactured, alongside research and development focused on patient health improvements. A subsidiary handles digital health technologies to support traditional treatments. A scientific campus is maintained for partnerships in health, science, and innovation. Operations cover the full value chain from research through production and distribution.
Zambon Pharma offers Zambon Pharma, Zach System, and Zcube.
Zambon Pharma has made 1 acquisition, including Breath Therapeutics.
Zambon Pharma has 1 investor. Key investors include European Investment Bank.